
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+9
Amprion is a global leader advancing precision medicine for neurodegenerative disorders through seed amplification testing. Amprions SAAmplifyTM-SYN (formerly SYNTap) Biomarker Test is a first-in-class, qualitative Laboratory Developed Test (LDT) and the only seed amplification assay available to aid the diagnosis of synucleinopathies such as Parkinsons disease (PD), Lewy body dementia (LBD/DLB), and Alzheimers disease (AD) with Lewy body variant
Abeta,tau,neurology,healthcare,early detection of parkinson's disease,lewy body dementia,alzheimer's disease,neurodegenerative disorders,alpha-synuclein,synucleinopathies,lewy body copathology,seed amplification assay,saa,and precision brain diagnostics
Amprion operates in the Biotechnology industry.
Amprion's revenue is 11m - 100m
Amprion has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.